Phase III Trial Exploring the Combination of Bevacizumab and Lomustine in Patients With First Recurrence of a Glioblastoma
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 18 Jun 2018
At a glance
- Drugs Bevacizumab (Primary) ; Lomustine
- Indications Glioblastoma
- Focus Therapeutic Use
- 15 Jun 2018 The study has been completed in Italy.
- 02 Jun 2018 The study has been completed in Germany (End date: 2018-02-10).
- 30 May 2018 The study has been completed in Netherlands.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History